Peptide that reverses the anticoagulant effect of heparin
(Cat. No. 2812). Potently binds heparin (Kd
= 36 nM in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold under license
Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist.
Cushing et al.
Development of heparin antagonists with focused biological activity.
Shenoy et al.